These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27402288)

  • 1. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
    Hammadi A; Billard C; Faussat AM; Kolb JP
    Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Non-Canonical, Inhibitory
    Cardona Gloria Y; Bernhart SH; Fillinger S; Wolz OO; Dickhöfer S; Admard J; Ossowski S; Nahnsen S; Siebert R; Weber ANR
    Front Immunol; 2021; 12():616451. PubMed ID: 34163463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
    J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular deregulation of signaling in lymphoid tumors.
    Spina V; Martuscelli L; Rossi D
    Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
    Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
    Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
    Carmody RJ; Chen YH
    Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.
    Tian J; Guo X; Liu XM; Liu L; Weng QF; Dong SJ; Knowlton AA; Yuan WJ; Lin L
    Cardiovasc Res; 2013 Jun; 98(3):391-401. PubMed ID: 23447644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
    Lee SM; Kim EJ; Suk K; Lee WH
    J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
    Chen R; Alvero AB; Silasi DA; Mor G
    Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
    Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
    Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NF-kappaB in hematologic malignancies.
    Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
    Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB.
    Gobec M; Prijatelj M; Delić J; Markovič T; Mlinarič-Raščan I
    Eur J Pharmacol; 2014 Nov; 742():81-8. PubMed ID: 25218986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol.
    Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K
    J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.